ICB Pharma sp. z o.o.

Manufacture of other organic basic chemicals

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2026-01-02
Share capital
1,000,000.00 PLN
Activity description

ICB Pharma is an international research company operating in human and animal health, crop protection, and pest management. Its research focuses on nano- and micro-encapsulation and the development of products for these fields.

Registered address
ul. Stanisława Lema 10, 43-603 Jaworzno, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-72182-28601-ADWAH-13

Financials

Filing timeliness

The financial statement for 2025 was filed on time and audited by a statutory auditor.

  • 202524/03/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing2,116 / 24,570
Top 8.6%
City · Jaworzno14 / 489
Top 2.9%
Voivodeship · Śląskie887 / 33,177
Top 2.7%
Country · Poland7,964 / 297,266
Top 2.7%

Results vs industry

Revenue
This companyUSD 28.06mMedianUSD 892.74kAverageUSD 17.04m
Net profit
This companyUSD 4.64mMedianUSD 36.66kAverageUSD 694.67k
Operating costs
This companyUSD 22.69mMedianUSD 891.12kAverageUSD 15.99m
Assets
This companyUSD 23.55mMedianUSD 1.07mAverageUSD 12.46m

Offer

Certifications: ISO 9001

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Tag Manager

Trademarks

The company holds 27 active trademarks registered with the Polish Patent Office. 2 applications are pending. The first mark was filed in 2002.

MarkNumberClassesStatusProtected until
SILICU (word)Z.5756001, 5Protected Oct 16, 2034
triabor (word)Z.5755991, 5Protected Oct 16, 2034
CALPRONE (word)Z.5671411, 5Protected Mar 13, 2034
TRIACYNK (word)Z.5671401, 5Protected Mar 13, 2034
DIFUNGOFF (word)Z.5597673, 5Protected Aug 28, 2033
MarkProtected until
SILICU (word)Oct 16, 2034
triabor (word)Oct 16, 2034
CALPRONE (word)Mar 13, 2034
TRIACYNK (word)Mar 13, 2034
DIFUNGOFF (word)Aug 28, 2033

Authorized Representatives

Paweł Świętosławski age 49 – Management Board Member
Tomasz Świętosławski age 52 – Management Board Member

Manner of representation

In the case of a one-person management board, the company is represented by a member of the management board acting independently. If the management board is multi-member, the company is represented by two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
10,000$135,062.1350%
10,000$135,062.1350%

Paweł Świętosławski and Tomasz Świętosławski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-09-11.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$570.3K
Buildings and premises
$3.3M

Public aid

30 public aid cases recorded, with a total value of $665,370.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$226
De minimis aid (in accordance with Commission Regulation 2023/2831)
$226
De minimis aid (in accordance with Commission Regulation 2023/2831)
$31,399

Competitors

Name
Bros sp. z o.o.
Verco S.A.
Pentagon Trade One sp. z o.o.
Pestila sp. z o.o.
Przedsiębiorstwo Wielobranżowe Vet-Agro sp. z o.o.
Bio-Gen sp. z o.o.
Agropak sp. j.
Vaco sp. z o.o.
Vet-Agro Trading sp. z o.o.
Fregata S.A.

FAQ

Last updated: 2026-03-24